KYMERA THERAPEUTICS I
43.17
08-十月-24 10:36:12
15 分钟延时
股票
+0.96
+2.27%
今日范围
42.41 - 43.37
ISIN
N/A
来源
NASDAQ
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
28 2月 2024 07:00:10 条件 Nasdaq GlobeNewswire
-
22 2月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
15 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference
31 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
09 1月 2024 09:17:00 条件 Nasdaq GlobeNewswire
-
09 1月 2024 09:15:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Pricing of $275 Million Public Offering
05 1月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Proposed Public Offering
04 1月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
04 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
02 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Host Virtual Immunology R&D Day on January 4
13 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
10 12月 2023 21:00:00 条件 Nasdaq GlobeNewswire
-
13 11月 2023 11:00:00 条件 Nasdaq GlobeNewswire
-
02 11月 2023 09:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
02 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
01 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Third Quarter 2023 Financial Results on November 2
26 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
16 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire